Marketing-authorisation holder · United States
Cycle
3 medicines in 1 country, as authorisation holder.
Group structure
Part of
CyclePharmaceutical groupOther companies in the group
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| HARLIKU2MG · Tablet | Nitisinone | United States | Marketed | 2017 |
| NITYR10mg | 2mg | 5mg · Tablet | Nitisinone | United States | Marketed | 2017 |
| TASCENSO ODT0.25mg base | 0.5mg base · Tablet, orally disintegrating | Fingolimod lauryl | United States | Marketed | 2022 |